|
Somatostatin analog; chemotherapy Clinical Trials
1 actively recruiting trial
Top Sponsors
- University of Roma La Sapienza1
Indications
- Neuroendocrine Carcinoma1
- Neuroendocrine Neoplasm1
- Neuroendocrine Tumor Grade 21
- Neuroendocrine Tumor Grade 11
- Neuroendocrine Tumors1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.